Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Metabolites 2012, 2(4), 1004-1011; doi:10.3390/metabo2041004

Glycomic Expression in Esophageal Disease

 and *
Received: 25 September 2012; in revised form: 5 November 2012 / Accepted: 9 November 2012 / Published: 21 November 2012
(This article belongs to the Special Issue Glycomics and Glycoproteomics)
View Full-Text   |   Download PDF [177 KB, uploaded 21 November 2012]
Abstract: Glycosylation is among the most common post translation modifications of proteins in humans. Decades of research have demonstrated that aberrant glycosylation can lead to malignant degeneration. Glycoproteomic studies in the past several years have identified techniques that can successfully characterize a glycan or glycan profile associated with a high-grade dysplastic or malignant state. This review summarizes the current glycomic and glycoproteomic literature with specific reference to esophageal cancer. Esophageal adenocarcinoma represents a highly morbid and mortal cancer with a defined progression from metaplasia (Barrett's esophagus) to dysplasia to neoplasia. This disease is highlighted because (1) differences in glycan profiles between the stages of disease progression have been described in the glycoproteomic literature; (2) a glycan biomarker that identifies a given stage may be used as a predictor of disease progression and thus may have significant influence over clinical management; and (3) the differences in glycan profiles between disease and disease-free states in esophageal cancer are more dramatic than in other cancers.
Keywords: esophageal adenocarcinoma; glycomics; glycoproteomics; biomarkers; cancer esophageal adenocarcinoma; glycomics; glycoproteomics; biomarkers; cancer
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Mohanty, S.; Tsiouris, A.; Hammoud, Z. Glycomic Expression in Esophageal Disease. Metabolites 2012, 2, 1004-1011.

AMA Style

Mohanty S, Tsiouris A, Hammoud Z. Glycomic Expression in Esophageal Disease. Metabolites. 2012; 2(4):1004-1011.

Chicago/Turabian Style

Mohanty, Sanjay; Tsiouris, Athanasios; Hammoud, Zane. 2012. "Glycomic Expression in Esophageal Disease." Metabolites 2, no. 4: 1004-1011.

Metabolites EISSN 2218-1989 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert